Stock Scorecard



Stock Summary for SomaLogic Inc - Class A (SLGC) - $2.10 as of 3/27/2024 6:50:24 AM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SLGC

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SLGC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SLGC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for SLGC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for SLGC

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock 3/18/2024 12:12:00 PM
InterDigital appoints Ken Kaskoun as Chief Growth Officer 2/12/2024 1:30:00 PM
Epigenetics Market is Expected to Reach $4.3 Billion | MarketsandMarkets. 1/12/2024 12:30:00 PM
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue 1/8/2024 1:30:00 PM
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue 1/8/2024 1:30:00 PM
Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools - Standard BioTools ( NASDAQ:LAB ) 1/5/2024 1:46:00 PM
Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools 1/5/2024 1:46:00 PM
Standard BioTools Stockholders Approve Merger with SomaLogic - Standard BioTools ( NASDAQ:LAB ) , SomaLogic ( NASDAQ:SLGC ) 1/5/2024 3:23:00 AM
Standard BioTools Stockholders Approve Merger with SomaLogic 1/5/2024 3:23:00 AM
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools - SomaLogic ( NASDAQ:SLGC ) 1/2/2024 1:00:00 PM

Financial Details for SLGC

Company Overview

Ticker SLGC
Company Name SomaLogic Inc - Class A
Country N/A
Description N/A
Sector Name TRADE & SERVICES
Industry Name SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Most Recent Quarter 9/30/2023
Next Earnings Date 3/26/2024

Stock Price History

Last Day Price 2.10
Last Day Price Updated 3/27/2024 6:50:24 AM EST
Last Day Volume 33,901,802
Average Daily Volume 2,915,414
52-Week High 3.55
52-Week Low 1.73
Last Price to 52 Week Low 21.39%

Valuation Measures

Trailing PE N/A
Industry PE 34.70
Sector PE 43.11
5-Year Average PE -6.84
Free Cash Flow Ratio 0.87
Industry Free Cash Flow Ratio 50.55
Sector Free Cash Flow Ratio 89.92
Current Ratio Most Recent Quarter 17.79
Total Cash Per Share 2.41
Book Value Per Share Most Recent Quarter 2.63
Price to Book Ratio 0.80
Industry Price to Book Ratio 8.75
Sector Price to Book Ratio 9.32
Price to Sales Ratio Twelve Trailing Months 4.85
Industry Price to Sales Ratio Twelve Trailing Months 4.29
Sector Price to Sales Ratio Twelve Trailing Months 2.00

Share Statistics

Total Shares Outstanding 188,679,000
Market Capitalization 396,225,900
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -24.68%
Reported EPS 12 Trailing Months -0.69
Reported EPS Past Year -0.43
Reported EPS Prior Year -0.59
Net Income Twelve Trailing Months -130,382,000
Net Income Past Year -109,157,000
Net Income Prior Year -87,547,000
Quarterly Revenue Growth YOY -47.10%
5-Year Revenue Growth 19.65%

Balance Sheet

Total Cash Most Recent Quarter 453,810,000
Total Cash Past Year 539,588,000
Total Cash Prior Year 657,706,000
Net Cash Position Most Recent Quarter 453,810,000
Net Cash Position Past Year 539,588,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 562,558,000
Total Stockholder Equity Prior Year 612,024,000
Total Stockholder Equity Most Recent Quarter 496,739,000

Options

Put/Call Ratio 0.75
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.03
MACD Signal -0.01
20-Day Bollinger Lower Band 1.80
20-Day Bollinger Middle Band 2.29
20-Day Bollinger Upper Band 2.78
Beta 1.64
RSI 41.48
50-Day SMA 2.53
200-Day SMA 0.00

System

Modified 3/27/2024 6:50:25 AM EST